Kvols L, Woltering E. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors. Anticancer Drugs. 2006, 17 (6): 601–8. PMID 16917205. doi:10.1097/01.cad.0000210335.95828.ed.
Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006, 17 (12): 1733–42. PMID 16801334. doi:10.1093/annonc/mdl105.
Kvols L, Woltering E. Role of somatostatin analogs in the clinical management of non-neuroendocrine solid tumors. Anticancer Drugs. 2006, 17 (6): 601–8. PMID 16917205. doi:10.1097/01.cad.0000210335.95828.ed.
Susini C, Buscail L. Rationale for the use of somatostatin analogs as antitumor agents. Ann Oncol. 2006, 17 (12): 1733–42. PMID 16801334. doi:10.1093/annonc/mdl105.